PriceTargets.com logo

4Front Ventures - FFNTF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.04 As of 10/29/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for FFNTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 4Front Ventures Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FFNTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FFNTF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for 4Front Ventures in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.04.

This chart shows the closing price for FFNTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in 4Front Ventures. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/16/2022Canaccord Genuity GroupLower TargetC$1.20 ➝ C$1.00
10/28/2022BTIG ResearchInitiated CoverageBuy
(Data available from 10/30/2019 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
4Front Ventures logo
4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.
Read More

Today's Range

Now: $0.04
Low: $0.04
High: $0.05

50 Day Range

MA: $0.05
Low: $0.04
High: $0.06

52 Week Range

Now: $0.04
Low: $0.03
High: $0.23

Volume

478,474 shs

Average Volume

311,482 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of 4Front Ventures?

The following Wall Street sell-side analysts have issued stock ratings on 4Front Ventures in the last year:
View the latest analyst ratings for FFNTF.

What is the current price target for 4Front Ventures?

0 Wall Street analysts have set twelve-month price targets for 4Front Ventures in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for 4Front Ventures in the next year.
View the latest price targets for FFNTF.

What is the current consensus analyst rating for 4Front Ventures?

4Front Ventures currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for FFNTF.

What other companies compete with 4Front Ventures?

Other companies that are similar to 4Front Ventures include 180 Life Sciences, 4D pharma, Abattis Bioceuticals, Aeolus Pharmaceuticals and Aesther Healthcare Acquisition. Learn More about companies similar to 4Front Ventures.

How do I contact 4Front Ventures' investor relations team?

4Front Ventures' physical mailing address is 5060 North 40th Street, Phoenix, AZ 85018. The company's listed phone number is (602) 633-3067. The official website for 4Front Ventures is 4frontventures.com. Learn More about contacing 4Front Ventures investor relations.